Navigation Links
Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
Date:10/16/2010

e at www.generex.com or the Antigen Express website at www.antigenexpress.com.  Information contained in, or accessible through, the websites of Generex or Antigen Express is not incorporated herein and is not a part of the proxy soliciting material.

Safe Harbor Statement

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not.  Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement.  No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements.  Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.  Generex cannot be sure when or if it will be permitted by regulatory agencies to undertake additional clinica
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
2. Generex Provides Clarification for Special Meeting Voting
3. Generex Reaches Agreement to Acquire 51% Stake in Global Medical Direct, a Nationwide Durable Medical Equipment and Pharmaceutical Provider Specializing in Direct-to-Consumer Diabetes Supplies
4. Generex Biotechnology Provides a Corporate Update to Address Managements Strategic Initiatives for Growth
5. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Announces Sales Agreement with Elias Shaker & Company
8. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
9. Generex Announces Presentations of Novel Vaccine Strategies
10. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
11. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... N.C. , July 11, 2014 ... approaches are evolving across industry sectors to better ... examining better ways to engage with and understand ... inform themselves and make critical purchasing decisions. ... firm, Best Practices, LLC, one area where organizations ...
(Date:7/11/2014)... Research and Markets has announced the addition ... Industry Report 2014" report to their offering. ... And Chinese Medical X-Ray Film Industry Report 2014 is ... of the Global medical X-ray film industry with a ... a basic overview of the industry including definitions, classifications, ...
(Date:7/11/2014)... 2014 Research and Markets  has announced ... 2014-2018" report to their offering. ... is a hollow needle commonly used with a syringe ... extract fluids from it. A hypodermic needle is used ... that cannot be ingested. Hypodermic needles are broadly classified ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global and Chinese Medical X-ray Film Industry Report 2014 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3
... (Nasdaq: NVAX ) announced today that it has ... H1N1 influenza vaccine in Mexico in collaboration with Avimex ... and pharmaceutical products for use in Mexico and more ... is providing financial support for the trial and is ...
... SHENYANG, China, Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio ... China-based biotechnology,company focused on researching, developing, manufacturing and marketing,biopharmaceutical ... of shareholders held on October 12, 2009. , ... re-elected Dr. Jing Lou and Mr.,Moujia Qi to serve ...
Cached Medicine Technology:Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5
(Date:7/14/2014)... Doctor Mike Hamilton from Inception Chiropractic ... company website. The Inception website is a place for ... It's also a place for potential clients to learn ... When contacted at his office, Doctor Hamilton said, "We're ... website. Our site is obviously a great place for ...
(Date:7/14/2014)... 2014 Love Digits LLC has successfully ... Digits. The App brings ancient astrology to the modern ... their compatibility using a five-star rating system. By entering ... instantaneously test their compatibility for love and marriage across ... app’s five-star rating system generates a weighted average of ...
(Date:7/14/2014)... Spine Team Texas continues to stay ... treatment and recovery. Currently all physical therapists at Spine ... for certification in The McKenzie Method. Two therapists, Craig ... program. , “We require certification of our therapists because ... outcomes for spine pain patients,” said Mark Hood, CEO ...
(Date:7/14/2014)... Townsend Security, a leading authority ... IBM i (AS/400, iSeries) Two Factor Authentication Partner ... threats evolve and make passwords ineffective for system ... their applications and implement two factor authentication (2FA). ... for ISVs on the IBM i platform to ...
(Date:7/14/2014)... Crystal Dental has recently announced that it will ... made via LAD Solutions in in order to increase awareness ... in order to draw in new patients that can now ... Dental offers a variety of services for both routine and ... include cosmetic dentistry procedures such as porcelain veneers and dental ...
Breaking Medicine News(10 mins):Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 2Health News:Love Digits, Numerical Approach to Modern Love, Now Available on iTunes 3Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 2Health News:Spine Team Texas’ Physical Therapists Complete The McKenzie Method Training and Certification 3Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 2Health News:IBM i ISVs Can Now Easily Integrate Mobile-Based Two Factor Authentication to Increase Security of Solutions 3Health News:Crystal Dental Announces the Opening of New Office Location in Sacramento 2
... Centre and Kenya has been asked to spell out, account ... intended 134 million. The fund was provided to Kenya to ... have to provide the accounts of how the money was ... Kenya has been ridden with serious corruption problems that have ...
... The burden of HIV, malaria and Tuberculosis in most ... //The European Union, UNAIDS, WHO and the Indian Government ... the diseases. ,"These diseases mostly affect the ... aim to share our experiences and develop strategies to ...
... drug manufactured by German pharmaceutical company TeGenero by medical research ... designed to treat rheumatoid arthritis, leukaemia and multiple sclerosis was ... who fell seriously ill after taking part in a drug ... brain was on fire. Student Nav Modi, 24, said that ...
... an NGO official India’s population stabilization solely rests on ... which has the highest fertility rates. ,'India's population ... an immediate lead in checking population growth' A.R. Nanda, ... ,'If high growth states like Bihar and Uttar Pradesh, ...
... funds to the tune of ?4m or more will be ... This spending should take care of containing// the unhealthy trend, ... gone up by almost 50%. ,A senior medical ... problems with suicidal tendencies, according to Mr Woodward. To enable ...
... high risk of the potentially-fatal condition of pre-eclampsia, should ... Vitamin C and E. // Recent research has suggested that ... and can trigger pre-eclampsia. ,Pre-eclampsia, is a dangerous condition ... women which is a common cause of deaths and still ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: